Managers / Q1 2026
AIHC Capital Management Ltd
CIK 0002103725 · UNIT 1506, 15/F, NEXXUS BUILDING, 41 CONNAUGHT ROAD CENTRAL, CENTRAL, 00000 · 85237579883
Summary
Aihc Capital Management Ltd reported $120M in U.S.-listed holdings across 5 positions for Q1 2026.
The portfolio is heavily concentrated: RVMD alone accounts for 67.4% of reported value.
Compared with Q4 2025, the fund opened 1 new position and exited 2.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 95.3% · $114M
- ADR · 4.7% · $6M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| ORICORIC PHARMACEUTICALS INC | NEW | +2.46M | 2.46M | +$31M | $31M |
| NBPNOVABRIDGE BIOSCIENCES | ADDED | +1.85M | 2.26M | +$4M | $6M |
| PTGXPROTAGONIST THERAPEUTICS INC | SOLD OUT | −189.8K | 0 | −$17M | $0 |
| AVBPARRIVENT BIOPHARMA INC | SOLD OUT | −644.8K | 0 | −$13M | $0 |
| COGTCOGENT BIOSCIENCES INC | TRIMMED | −48.6K | 51.4K | −$2M | $2M |
| RVMDREVOLUTION MEDICINES INC | TRIMMED | −71.4K | 829.0K | +$9M | $81M |
| KRROKORRO BIO INC | HELD | +0 | 30.3K | +$100,177 | $342,600 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2026
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | RVMDREVOLUTION MEDICINES INChistory → | COM | 67.37% | $81M | 829.0K |
| 2 | ORICORIC PHARMACEUTICALS INChistory → | COM | 26.04% | $31M | 2.46M |
| 3 | NBPNOVABRIDGE BIOSCIENCEShistory → | SPONSORED ADS | 4.65% | $6M | 2.26M |
| 4 | COGTCOGENT BIOSCIENCES INChistory → | COM | 1.65% | $2M | 51.4K |
| 5 | KRROKORRO BIO INC | COM | 0.29% | $342,600 | 30.3K |
Filing History
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.